|
|
Article: WellGen, Inc. Receives Investment from Amphion Capital Partners LLC; Amphion's CEO, Richard C. E. Morgan, to Join WellGen Board.
- Article from:
- Business Wire
- Article date:
- March 24, 2004
CopyrightCOPYRIGHT 2004 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Business Editors/Health/Medical Writers
NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--March 24, 2004
WellGen, Inc., a biotechnology company using nutragenomics to develop wellness products from plants that alter the expression of genes responsible for human disease, announced today that it has received $3 million in the form of equity capital, through a private offering of preferred stock, from venture-capital investors led by Amphion Capital Partners LLC. The funding will enable WellGen to introduce its first product, currently in clinical trials, and to advance other identified compounds to the human clinical trial stage, as well as to identify additional ...
Related newspaper, magazine, and journal articles:
|
|
Article: AXCESS' Active RFID Personalizes Marketing for Retail Stores.
PR Newswire;
May 18, 2005 ;
700+ words
... ... management, sensor management, and network-based security surveillance. AXCESS is a partner company of Amphion Capital Partners LLC. About Awarea Corporation Awarea was incorporated in 2004 after four years of development and commercial ...
|
|